Texas Capital Bank Wealth Management Services Inc Biogen Inc. Transaction History

Texas Capital Bank Wealth Management Services Inc

$1.02 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 15, 2024	BUY	$190.52 - $236.72 $193,949 - $240,980	1,018 New	1,018 $235,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.49 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.43 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.17 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.09 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$765 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Capital Bank Wealth Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Texas Capital Bank Wealth Management Services Inc with notifications on news.

Account